Analysis of Continuous Glucose Monitoring Data to Assess Outpatient Closed-Loop Studies: Considerations for Different Sensors

Abstract

Get full access to this article

View all access options for this article.

References

Hovorka

, Nodale

, Haidar

, Wilinska

: Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward. Diabetes Technol Ther, 2013; 15:4–12.

Haidar

, Legault

, Dallaire

, Alkhateeb

, Coriati

, Messier

, Cheng

, Millette

, Boulet

, Rabasa-Lhoret

: Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. CMAJ, 2013; 185:297–305.

Calhoun

, Lum

, Beck

, Kollman

: Performance comparison of the Medtronic Sof-Sensor and Enlite glucose sensors in inpatient studies of individuals with type 1 diabetes. Diabetes Technol Ther, 2013; 15:758–761.

Beck

, Calhoun

, Kollman

: Use of continuous glucose monitoring as an outcome measure in clinical trials. Diabetes Technol Ther, 2012; 14:877–882.